Ad
Thursday, 31 August 2017
AstraZeneca aims to offset drug setback at big cancer congress
LONDON (Reuters) - After last month's big clinical trial setback in lung cancer, AstraZeneca will seek to rebuild its oncology reputation next week when it unveils full details of two key clinical trials tackling the disease in different ways.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment